Abstract
Venous thromboembolism (VTE) is a leading cause of maternal morbidity and mortality worldwide. Despite the impact of VTE on pregnant and postpartum people and on society, guidelines addressing prevention, diagnosis, and management of VTE in pregnant and postpartum people frequently are based on recommendations from expert opinion and are extrapolated from data in nonpregnant populations. Pregnant individuals are frequently excluded from clinical trials, which is a barrier to providing safe, effective care. Anchoring to a case discussion, this review provides an update on recently published and ongoing randomized clinical trials (RCTs), prospective clinical management studies, and other research in this area. It highlights, in particular, the results of the Highlow RCT, which addresses optimal prevention of recurrence during pregnancy in people with prior VTE. Finally, we raise awareness of the impact of national and international clinical trial networks on the conduct of RCTs in pregnancy. We conclude, based on these data, that academic VTE clinical trials in pregnant women can and must be done.
References
1.
Ewins
K
, Ní Ainle
F
. VTE risk assessment in pregnancy
. Res Pract Thromb Haemost
. 2020
;4
(2
):183
-192
. doi:10.1002/rth2.12290.
2.
Konstantinides
SV
, Meyer
G
. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism
Eur Heart J
. 2019
;40
(42
): 3453
-3455
. doi:10.1093/eurheartj/ehz726
.3.
Abdul Sultan
A
, Tata
LJ
, Grainge
MJ
, West
J
. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis
. PLoS One
. 2013
;8
(7
):e70310
. doi:10.1371/journal.pone.0070310.
4.
van Mens
TE
, Scheres
LJ
, de Jong
PG
, Leeflang
MM
, Nijkeuter
M
, Middeldorp
S
. Imaging for the exclusion of pulmonary embolism in pregnancy
. Cochrane Database Syst Rev
. 2017
;1
(1
):CD011053
. doi:10.1002/14651858.CD011053.pub2.
5.
Sheen
J-J
, Haramati
L-B
, Natenzon
A
, et al. Performance of low-dose perfusion scintigraphy and CT pulmonary angiography for pulmonary embolism in pregnancy
. Chest
. 2018
;153
(1
):152
-160
. doi:10.1016/j.chest.2017.08.005.
6.
Gillespie
C
, Foley
S
, Rowan
M
, Ewins
K
, NiAinle
F
, MacMahon
P
. The OPTICA study (Optimised Computed Tomography Pulmonary Angiography in Pregnancy Quality and Safety study): rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy
. Thromb Res
. 2019
;177
:172
-179
. doi:10.1016/j.thromres.2019.03.007.
7.
Mitchell
DP
, Rowan
M
, Loughman
E
, Ridge
CA
, MacMahon
PJ
. Contrast monitoring techniques in CT pulmonary angiography: an important and underappreciated contributor to breast dose
. Eur J Radiol
. 2017
;86
:184
-189
. doi:10.1016/j.ejrad.2016.11.011.
8.
Gillespie
CD
, Yates
A
, Murphy
MC
, et al. Breast shielding combined with an optimized computed tomography pulmonary angiography pregnancy protocol: a special use-case for shielding?
J Thorac Imaging
. 2023
;38
(1
): 36
-43
. doi:10.1097/rti.0000000000000677.
9.
Hunt
BJ
, Parmar
K
, Horspool
K
, et al. The DiPEP (Diagnosis of PE in Pregnancy) biomarker study: an observational cohort study augmented with additional cases to determine the diagnostic utility of biomarkers for suspected venous thromboembolism during pregnancy and puerperium
. Br J Haematol
. 2018
;180
(5
):694
-704
. doi:10.1111/bjh.15102.
10.
Goodacre
S
, Horspool
K
, Nelson-Piercy
C
, et al; DiPEP research group
. The DiPEP study: an observational study of the diagnostic accuracy of clinical assessment, D-dimer and chest x-ray for suspected pulmonary embolism in pregnancy and postpartum
. BJOG
. 2019
;126
(3
):383
-392
. doi:10.1111/1471-0528.15286.
11.
Righini
M
, Robert-Ebadi
H
, Elias
A
, et al; CT-PE-Pregnancy Group
. Diagnosis of pulmonary embolism during pregnancy: a multicenter prospective management outcome study
. Ann Intern Med
. 2018
;169
(11
):766
-773
. doi:10.7326/M18-1670.
12.
van der Pol
LM
, Tromeur
C
, Bistervels
IM
, et al. Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism
. N Engl J Med
. 2019
;380
(12
):1139
-1149
. doi:10.1056/NEJMoa1813865.
13.
Langlois
E
, Cusson-Dufour
C
, Moumneh
T
, et al. Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT-PE-pregnancy study
. J Thromb Haemost
. 2019
;17
(8
):1329
-1334
. doi:10.1111/jth.14483.
14.
Stals
MAM
, Moumneh
T
, Ainle
FN
, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data
. J Thromb Haemost
. 2023
;21
(3
):606
-615
. doi:10.1016/j.jtha.2022.11.025.
15.
Robert-Ebadi
H
, Elias
A
, Sanchez
O
, et al. Assessing the clinical probability of pulmonary embolism during pregnancy: the Pregnancy-Adapted Geneva (PAG) score
. J Thromb Haemost
. 2021
;19
(12
):3044
-3050
. doi:10.1111/jth.15521.
16.
Righini
M
, Jobic
C
, Boehlen
F
, et al. Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule
. Haematologica
. 2013
;98
(4
):545
-548
. doi:10.3324/haematol.2012.072009.
17.
Le Moigne
E
, Genty
C
, Meunier
J
, et al; OPTIMEV Investigators
. Validation of the LEFt score, a newly proposed diagnostic tool for deep vein thrombosis in pregnant women
. Thromb Res
. 2014
;134
(3
):664
-667
. doi:10.1016/j.thromres.2014.07.009.
18.
Samuelson Bannow
B
, Federspiel
JJ
, Abel
DE
, Mauney
L
, Rosovsky
RP
, Bates
SM
. Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee
. J Thromb Haemost
. 2023
;21
(6
):1432
-1440
. doi:10.1016/j.jtha.2023.03.015.
19.
Leffert
L
, Butwick
A
, Carvalho
B
, et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants
. Anesth Analg
. 2018
;126
(3
):928
-944
. doi:10.1213/ane.0000000000002530.
20.
Royal College of Obstetricians and Gynaecologists. Green Top Guideline No. 37b
(2015
). Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management
. Royal College of Obstetricians and Gynaecologists, UK
.21.
Say
L
, Chou
D
, Gemmill
A
, et al. Global causes of maternal death: a WHO systematic analysis
. Lancet Glob Health
. 2014
;2
(6
):e323
-e333
. doi:10.1016/s2214-109x(14)70227-x.
22.
Côté-Poirier
G
, Bettache
N
, Côté
A-M
, et al. Evaluation of complications in postpartum women receiving therapeutic anticoagulation
. Obstet Gynecol
. 2020
;136
(2
):394
-401
. doi:10.1097/AOG.0000000000003971.
23.
Simard
C
, Gerstein
L
, Cafaro
T
, et al; Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
. Bleeding in women with venous thromboembolism during pregnancy: a systematic review of the literature
. Res Pract Thromb Haemost
. 2022
;6
(6
): e12801
. doi:10.1002/rth2.12801.
24.
Berg
CJ
, Callaghan
WM
, Syverson
C
, Henderson
Z
. Pregnancy-related mortality in the United States, 1998 to 2005
. Obstet Gynecol
. 2010
;116
(6
): 1302
-1309
. doi:10.1097/aog.0b013e3181fdfb11.
25.
Tardy
B
, Chalayer
E
, Kamphuisen
PW
, et al; SSC Subcommittee on Control of Anticoagulation of the ISTH
. Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: a systematic review and a proposal from the ISTH SSC
. J Thromb Haemost
. 2019
;17
(11
):1979
-1988
. doi:10.1111/jth.14576.
26.
Klok
FA
, Ageno
W
, Ay
C
, et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society
. Eur Heart J
. 2022
;43
(3
):183
-189
. doi:10.1093/eurheartj/ehab816.
27.
Bistervels
IM
, Buchmüller
A
, Wiegers
HMG
, et al; Highlow Block writing committee
; Highlow Investigators
. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicenter, randomised, controlled trial
. Lancet
. 2022
;400
(10365
):1777
-1787
. doi:10.1016/S0140-6736(22)02128-6.
28.
Pabinger
I
, Grafenhofer
H
, Kaider
A
, et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis
. J Thromb Haemost
. 2005
;3
(5
):949
-954
. doi:10.1111/j.1538-7836.2005.01307.x.
29.
De Stefano
VD
, Martinelli
I
, Rossi
E
, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis
. Br J Haematol
. 2006
;135
(3
):386
-391
. doi:10.1111/j.1365-2141.2006.06317.x.
30.
White
RH
, Chan
W-S
, Zhou
H
, Ginsberg
J-S
. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism
. Thromb Haemost
. 2008
;100
(2
):246
-252
.
31.
Rodger
M
. Pregnancy and venous thromboembolism: ‘TIPPs' for risk stratification
. Hematology Am Soc Hematol Educ Program
. 2014
;2014
(1
): 387
-392
. doi:10.1182/asheducation-2014.1.387.
32.
Bates
SM
, Rajasekhar
A
, Middeldorp
S
, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
. Blood Adv
. 2018
;2
(22
): 3317
-3359
. doi:10.1182/bloodadvances.2018024802.
33.
Bates
SM
, Greer
IA
, Middeldorp
S
, Veenstra
DL
, Prabulos
A-M
, Vandvik
PO
. VTE, thrombophilia, antithrombotic therapy, and pregnancy
. Chest
. 2012
;141
(2
):e691S
-e736S
. doi:10.1378/chest.11-2300.
34.
Royal College of Obstetricians and Gynaecologists. Green Top Guideline No. 37a
(2015
). Reducing the Risk of Venous Thromboembolism During Pregnancy and the Puerperium
. Royal College of Obstetricians and Gynaecologists, UK
.35.
O'Shaughnessy
F
, Donnelly
JC
, Bennett
K
, Damkier
P
, Áinle
FN
, Cleary
BJ
. Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population
. J Thromb Haemost
. 2019
;17
(11
):1875
-1885
. doi:10.1111/jth.14568.
36.
O'Shaughnessy
F
, Donnelly
JC
, Cooley
SM
, et al. Thrombocalc: implementation and uptake of personalized postpartum venous thromboembolism risk assessment in a high-throughput obstetric environment
. Acta Obs Gynecol Scand
. 2017
;96
(11
):1382
-1390
. doi:10.1111/aogs.13206.
37.
Andrew
L
, Ní Áinle
F
, Blondon
M
, Rodger
MA
, Skeith
L
. Preventing postpartum venous thromboembolism: a call to action to reduce undue maternal morbidity and mortality
. Thromb Res
. 2020
;193
(1
):190
-197
. doi:10.1016/j.thromres.2020.07.007.
38.
Rodger
MA
, Phillips
P
, Kahn
SR
, James
AH
, Konkle
BA
; PROSPER Investigators
. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial
. Thromb Haemost
. 2015
;113
(1
):212
-216
. doi:10.1160/TH14-06-0485.
39.
Anderson
DR
, Dunbar
MJ
, Bohm
ER
, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial
. Ann Intern Med
. 2013
;158
(11
): 800
-806
. doi:10.7326/0003-4819-158-11-201306040-00004.
40.
Anderson
DR
, Dunbar
M
, Murnaghan
J
, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty
. N Engl J Med
. 2018
;378
(8
): 699
-707
. doi:10.1056/NEJMoa1712746.
41.
Blondon
M
, et al. OC 25.4 - Preventing postpartum venous thromboembolism with low-molecular-weight heparin: a feasibility randomized controlled trial
. Res Pract Thromb Haemost
. 2023
(suppl in press).42.
Koumoutsea
EV
, Malinowski
AK
, Kaplovic
E
, Lomash
R
, Murphy
K
. LEAP Pilot: low molecular weight heparin vs. aspirin postpartum
. Blood
. 2022
;140
(suppl 1
):341
-342
. doi:10.1182/blood-2022-156609.
43.
Chauleur
C
, Gris
J-C
, Laporte
S
, et al; STRATHEGE Investigators and The STRATHEGE Group
. Benefit of risk score-guided prophylaxis in pregnant women at risk of thrombotic events: a controlled before-and-after implementation study
. Thromb Haemost
. 2018
;118
(9
):1564
-1571
. doi:10.1055/s-0038-1668524.
44.
Malhamé
I
, Hardy
E
, Cheng
MP
, Tong
SYC
, Bowen
AC
. Walking the walk to include pregnant participants in non-obstetric clinical trials: insights from the SNAP Trial. Obstetric Medicine
. Obs Med
. 2023
;16
(1
):3
-4
. doi:10.1177/1753495x231163351.
45.
Tardy
B
, Buchmuller
A
, Bistervels
IM
, Ni Ainle
F
, Middeldorp
S
. Thromboprophylaxis in pregnant women: for whom and which LMWH dosage?
J Thromb Haemost
. 2019
;17
(8
):1401
-1403
. doi:10.1111/jth.14547.
Copyright © 2023 by The American Society of Hematology
2023
You do not currently have access to this content.
